Astec LifeSciences profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |||||
|---|---|---|---|---|---|---|
| −25.9% | −25.9% | −44.6% | −11.9% | 6.3% | ||
| −8.9% | −8.9% | −14.5% | −4.8% | 2.7% | ||
| −10.3% | −10.3% | −20.1% | −8.2% | 9.9% | ||
| −6.7% | −6.0% | −13.3% | −3.7% | 4.1% | ||
Margins | ||||||
| −1.7% | −1.0% | −17.4% | −1.3% | 12.1% | ||
| −11.0% | −11.0% | −28.8% | −9.2% | 6.8% | ||
| — | 90.5% | 88.1% | 49.9% | — | ||
| −18.2% | −18.1% | −37.0% | −13.5% | 5.6% | ||
| −18.1% | −18.1% | −35.3% | −10.2% | 4.1% | ||
| −18.1% | −18.1% | −35.3% | −10.2% | 4.1% | ||
| −19.2% | −19.2% | −7.9% | −27.3% | −6.8% | ||
Additional | ||||||
| 0.3% | 0.2% | 4.5% | 24.1% | 26.8% | ||
| — | 0.0% | 0.0% | −6.3% | 11.5% | ||
| −25.9% | −25.9% | −44.6% | −12.6% | 5.5% | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.